July 1, 2026 | #HearFromHer #PretermBirth
For decades, the rate of spontaneous preterm birth in the United States has hovered stubbornly around 10%. Despite advancements in other areas of medicine, prematurity remains the second leading cause of death for neonates, carrying a heavy toll of lifelong health complications, developmental disabilities, and a staggering $25 billion annual cost to the healthcare system.

Listen to the full episode here.
As discussed in the latest Hear From Her podcast, the challenge has always been prediction. “Prior to this, we had very few tools to help predict who is at risk,” explains Dr. Mollie McDonnold, a Maternal-Fetal Medicine specialist. Traditionally, doctors relied on a patient’s history of previous preterm births, but the majority of cases occur in women with no prior history.
The Biomarker Breakthrough
The conversation highlights a shift toward personalized medicine through the use of biomarkers. By analyzing proteins from the placenta via a simple blood draw early in pregnancy, clinicians can now identify high-risk patients with much greater sensitivity than traditional methods.
Listen to the full episode here.
The Power of the “Bundle”
Identification is only half the battle; prevention is the goal. Zhenya Lindgardt, CEO of Sera Prognostics, shares results from the “Prime Study,” which utilized a protocol designed with the Society for Maternal-Fetal Medicine. When high-risk women were treated with a “preventive bundle”—consisting of low-dose aspirin, vaginal progesterone, and weekly nurse check-ins—the results were “spectacular”:
Listen to the full episode here.
A Tailored Future
The future of maternal health lies in moving away from a “one size fits all” approach. By stratifying care, healthcare providers can funnel intensive resources—like cervical length monitoring and specialized nurse support—to those who need it most, while providing peace of mind to those at low risk. As Lindgardt notes, the goal is to ensure every pregnancy receives the specific level of care it requires to thrive.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Medscape Education Global to Present Symposia and Posters at the European Academy of Dermatology and Venereology 2022 (EADV)
The latest results of the GP and Hospital Doctor Media Surveys reveal that the Medscape Professional Network* (MPN) is amongst the leading destinations for doctors in the UK. Of those surveyed,…
Medscape Education Global to Deliver Educational Opportunities at European Society for Medical Oncology (ESMO) 2022
Medscape Education Global will attend ESC from September 26-29 to host live symposia and an in-person event on key topics in cardiology.
Medscape Education, the leading destination for continuous professional development for healthcare professionals, has launched Building Bridges Between Mental Health and Wellness, a learning center focusing on mental health and wellness for both patients…
Medscape Education has been awarded Accreditation with Commendation, the highest designation possible by the Joint Accreditation for Interprofessional Continuing Education™, ensuring quality accredited continuing education for members of the healthcare…
Spotlight on CLLAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Prof John Gribben, UK, on the most important abstracts to look out for in…
Spotlight on LymphomaAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Dr Loretta Nastoupil, US, on the most important abstracts to look out for in…
A MEDSCAPE DIGITAL HEALTH AND INNOVATION EVENT
The world of medical device technology is constantly evolving. From wearable devices to diagnostic technology, clinicians have more options than ever for monitoring and assessing their patients’ health. The accessibility…
